Mortality to 2 years (%) | Mortality to 5 years (%) | |
---|---|---|
Hgb (g/dl) at baseline and localisation | 26.56 | - |
ASA class | 9.90 | - |
Residual tumour classification | 19.78 | - |
TNM | 16.32 | - |
LODDS | 17.76 | 3.19 |
Complications during admission | 6.27 | - |
Invasion: vascular, perineural, lymphatic | 3.41 | 1.82 |
Diagnosis tests performed within the first year of follow-up | - | 22.61 |
Any complication due to the treatment within the 2 year follow-up | - | 9.46 |
Age at baseline & Radiotherapy treatment within the 2 year follow-up | - | 12.60 |
Colostomy closure within the 2-year follow-up period | - | 9.65 |
Medical complications within the 2-year follow-up period | - | 10.27 |
Tumour recurrence within the 2-year follow-up period | - | 14.50 |
Readmissions within the 2-year follow-up period | - | 15.89 |